Optimizing management of recurrent epithelial ovarian cancer: a critical need for evidence-based data.
Markman
Maurie
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002277:Carcinoma / Q000601:surgery / Q000628:therapy*; D002986:Clinical Trials as Topic; D019008:Drug Resistance, Neoplasm; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000628:therapy*; D012008:Recurrence; D012107:Research Design; D018570:Risk Assessment; D016879:Salvage Therapy / Q000592:standards*
D000970:Antineoplastic Agents